PCOS Is Now PMOS: What the New Medical Name Means for You
For decades, millions of women have been diagnosed with a condition whose name never quite matched their experience. "Polycystic ovary syndrome" suggested a problem confined to the ovaries and defined by cysts. But patients living with the condition often found themselves explaining that their struggles went far deeper—encompassing metabolism, mood, skin, weight, and long-term health risks that had little to do with cysts at all.
On May 12, 2026, that disconnect was formally addressed. An international consortium announced that polycystic ovary syndrome (PCOS) will now be known as polyendocrine metabolic ovarian syndrome, or PMOS. The change follows the largest disease-renaming effort in medical history and reflects a fundamental shift in how clinicians understand this common but frequently misunderstood condition.
Here is the direct answer: PMOS is the new medical name for what was previously called PCOS. The name was changed because the old term was scientifically misleading—people with this condition do not have an increase in abnormal ovarian cysts—and it failed to capture the hormonal and metabolic nature of the disorder. The new name emphasizes that this is a whole-body endocrine and metabolic condition, not simply an ovarian one.
This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. If you have symptoms, a medical condition, or questions about your care, speak with a qualified healthcare professional.
Seek urgent medical help if you experience severe or sudden pelvic pain, very heavy bleeding that soaks through a pad in an hour for two or more hours, signs of high blood sugar such as extreme thirst and frequent urination with confusion, or if you have thoughts of harming yourself.
Quick Summary
- PCOS is now called PMOS. The new name stands for polyendocrine metabolic ovarian syndrome.
- The change was driven by 14 years of global research and input from over 22,000 patients and health professionals.
- The old name was misleading: PMOS is not caused by cysts, and it affects metabolism, hormones, mental health, and skin—not just reproduction.
- A three-year transition is underway, with full implementation expected in the 2028 International Guideline update.
- Your existing diagnosis, care plan, and treatments do not change because of the new name.
Key Takeaway
The shift from PCOS to PMOS is about accuracy and respect. It removes a misleading focus on cysts and places hormones and metabolism at the center of the conversation—where they have always belonged.
Why the Name Changed
The push to rename PCOS began in earnest in 2015, when experts gathered in Sicily and agreed on one thing: the existing name was causing real harm. Over the following 14 years, Professor Helena Teede at Monash University in Australia led a global effort that included 56 patient and professional organizations, surveys completed by more than 22,000 stakeholders, and multiple international workshops.
The problem with "polycystic ovary syndrome" was twofold. First, it was scientifically inaccurate. Research has shown there is no increase in abnormal cysts on the ovaries in this condition. What ultrasound sometimes reveals are arrested follicles—small, fluid-filled sacs that are a normal part of ovarian function—not the pathological cysts the name implies. Second, the name reduced a complex, lifelong endocrine disorder to a reproductive curiosity. Because doctors and patients alike focused on ovaries and cysts, the metabolic, psychological, and dermatological dimensions of the condition were often overlooked.
This narrow framing had consequences. The World Health Organization estimates that roughly 70% of people with the condition remain undiagnosed. Many patients reported seeing multiple health professionals before receiving clarity, while others were dismissed because they did not have the ovarian "cysts" their doctor expected. Some were told to return only when they wanted to conceive, leaving metabolic and mental health concerns unaddressed for years.
The new name—polyendocrine metabolic ovarian syndrome—was chosen to correct both issues. "Polyendocrine" reflects the multiple hormone systems involved. "Metabolic" acknowledges the condition's impact on weight, insulin sensitivity, blood sugar, cholesterol, and cardiovascular risk. "Ovarian" was retained after extensive cultural consultation because alternatives such as "reproductive" were considered potentially stigmatizing in some regions, and because the term captures hormonal and follicular activity within the ovary without implying cystic disease.
The final vote was decisive. Among 90 voters representing clinicians, researchers, and patient advocates, 87 supported PMOS immediately. The decision was published in The Lancet and presented at the European Congress of Endocrinology in Prague. A three-year international education and awareness campaign will support the transition, with the new name fully implemented in the 2028 International Guideline update.
What PMOS Actually Is
PMOS is a common hormonal condition thought to affect at least one in eight women worldwide—more than 170 million people. It is characterized by fluctuations in hormones that can affect multiple body systems.
Clinically, diagnosis has traditionally relied on the Rotterdam criteria: the presence of at least two of three features—hyperandrogenism (excess androgen activity), ovulatory dysfunction (irregular or absent periods), and polycystic-appearing ovaries on ultrasound—after ruling out other causes. Importantly, the name change does not alter these diagnostic criteria overnight. However, by reframing the condition as endocrine and metabolic, advocates hope clinicians will place greater emphasis on metabolic screening and long-term health management, not just menstrual regularity and fertility.
The condition exists on a spectrum. Some people experience severe acne, excess facial or body hair, scalp hair thinning, and weight gain. Others struggle with irregular periods, fertility challenges, or mood disturbances. Many face an elevated risk of insulin resistance, type 2 diabetes, fatty liver disease, sleep apnea, depression, anxiety, and endometrial cancer.
What Causes or Contributes to PMOS
The exact cause remains unclear, but evidence points to a combination of genetic and environmental factors. Insulin resistance appears to play a central role. When the body's cells do not respond effectively to insulin, the pancreas produces more of it. Elevated insulin can drive the ovaries to produce excess androgens, which in turn disrupts ovulation and contributes to symptoms like acne and unwanted hair growth.
There is also evidence of dysregulation in the hypothalamic-pituitary-ovarian axis, with an imbalance between luteinizing hormone and follicle-stimulating hormone that favors androgen production. Genetics likely set the stage, while lifestyle factors such as diet, physical activity, sleep, and stress can influence how the condition expresses itself. Obesity is common in people with PMOS and can worsen both symptoms and metabolic risks, though people of all body sizes can be affected.
Biology Made Simple
Think of PMOS as a hormonal orchestra where several instruments are playing out of tune. Androgens such as testosterone are too loud. Insulin, which should help regulate blood sugar, is working overtime because the body's cells have become resistant to its signal. The brain's signaling to the ovaries is altered, so eggs do not mature and release on schedule. The result is a cascade that affects not just the reproductive system, but metabolism, skin, mood, and long-term heart health.
The "cysts" in the old name were never really cysts. They were small, arrested follicles—underdeveloped eggs that did not reach maturity. This is a normal variant seen in many people without PMOS, which is why relying on ultrasound alone can be misleading.
What You Can Safely Do
If you have been diagnosed with PCOS—or now PMOS—there are practical steps you can take that are safe and evidence-informed.
Track your symptoms. Note your menstrual cycle, skin changes, mood patterns, energy levels, and any new symptoms. This information is valuable for clinical appointments.
Ask about metabolic screening. Because PMOS carries risks for insulin resistance, type 2 diabetes, and cardiovascular disease, ask your clinician whether screening for blood glucose, cholesterol, and blood pressure is appropriate for you.
Prioritize sustainable habits. Regular physical activity, adequate sleep, and a balanced eating pattern can help improve insulin sensitivity and support overall wellbeing. These are general health principles, not a cure, and they should be approached gently rather than punitively.
Address mental health. Depression and anxiety are more common in people with PMOS. If you are struggling, speak with a clinician or mental health professional. Support groups and peer communities can also provide understanding.
Do not stop or change any prescribed medications because of the name change. The renaming does not alter treatment guidelines. If you have questions about your current plan, discuss them with your qualified healthcare provider.
Common Mistakes to Avoid
Believing it is only about fertility. PMOS is a lifelong condition with metabolic and psychological dimensions that extend far beyond the reproductive years.
Assuming an ultrasound diagnosis is definitive. Polycystic-appearing ovaries are common and nonspecific. A diagnosis requires clinical and biochemical evaluation, not just imaging.
Ignoring metabolic risks. Because the old name emphasized ovaries, many people never had their blood sugar, lipids, or blood pressure checked. The new name aims to correct this oversight.
Blaming yourself for weight gain. Weight gain is often a symptom of underlying insulin resistance, not a moral failing. Weight stigma can worsen health outcomes and should be avoided in clinical settings.
Waiting for symptoms to resolve on their own. Irregular periods and metabolic changes rarely fix themselves without support. Early, comprehensive care matters.
A Realistic Scenario
Composite example, not a real patient.
Sarah, 28, had irregular periods since her teens. Her doctor mentioned "borderline PCOS" after an ultrasound showed follicles, but told her not to worry until she wanted to conceive. For years, Sarah struggled with weight gain, anxiety, and fatigue that she attributed to poor discipline. After reading about the PMOS renaming, she asked her GP for metabolic screening and learned she had insulin resistance and elevated cholesterol. With lifestyle support and appropriate monitoring, she felt better within months—and finally understood that her symptoms were part of a recognized medical condition, not personal failure.
Myth vs. Fact
Myth: PMOS means you have dangerous cysts on your ovaries.
Fact: The condition is not defined by cysts. What appears on ultrasound are often arrested follicles, and research shows no increase in abnormal cysts in people with this syndrome.
Myth: The name change means you need new tests or treatments.
Fact: The diagnostic criteria and management approaches remain the same for now. The change is about language, accuracy, and reducing stigma.
Myth: PMOS only affects women who want to get pregnant.
Fact: It is a lifelong endocrine and metabolic condition that affects mental health, skin, weight, metabolism, and cardiovascular risk across all life stages.
Myth: You cannot get pregnant if you have PMOS.
Fact: Many people with PMOS conceive spontaneously or with support. Fertility challenges are common but not absolute, and treatment options are available.
When to See a Doctor
You should see a clinician if you have irregular or absent periods, signs of excess androgen such as new facial hair or severe acne, difficulty managing your weight alongside other symptoms, or concerns about fertility.
Guidance may vary by country, so check local health services or speak with a clinician.
Smart Questions to Ask Your Clinician
- "Given the new understanding of this condition as metabolic and endocrine, should I have screening for blood sugar, cholesterol, and blood pressure?"
- "How can we address my symptoms holistically, beyond just fertility or periods?"
- "Are there lifestyle changes or support services that could help with my specific symptom pattern?"
Frequently Asked Questions
Will my medical records automatically change from PCOS to PMOS?
Not immediately. A three-year transition period is underway, with full implementation expected in the 2028 International Guideline update. During this time, you may see both terms used. Your diagnosis and care remain valid regardless of the label on your chart.
Does the new name mean my condition is more serious than I thought?
No. The condition itself has not changed—only our understanding and description of it. The new name is intended to give you and your clinicians a clearer, more complete picture of what to monitor and manage over time.
If I don't have cysts, can I still have PMOS?
Yes. The presence of polycystic-appearing ovaries is only one possible feature of the condition, and it is neither required nor definitive. Many people are diagnosed based on hormonal and menstrual criteria alone.
Why keep 'ovarian' in the name at all?
The consortium considered removing any reference to ovaries to allow for emerging research on male phenotypes. However, after extensive cultural consultation, "ovarian" was retained because "reproductive" was considered stigmatizing in some regions, and because the term captures ovarian hormonal activity without implying cystic disease.
Does this change affect treatment guidelines?
For now, no. Current management remains based on existing international guidelines. Over time, the hope is that the reframing will encourage more comprehensive metabolic and mental health care alongside traditional gynecological management.
Written by:
Ibrahim Abdo, Health Content Specialist and Evidence-Based Medical Writer focused on translating complex health information into clear, trustworthy, reader-friendly insights.
Medical review status:
Not medically reviewed. This article was editorially fact-checked and is for educational purposes only.
Published:
May 12, 2026
Sources:
Sources are listed below and were checked for direct relevance to the medical claims in this article.
Last updated:
May 12, 2026
Editorial standard:
This article was created using evidence-based sources and reviewed for clarity, accuracy, and reader safety.
Sources
- The Lancet. "Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome." https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00717-8/fulltext. Published: May 12, 2026. Supports: The official announcement of the PMOS name change, publication details, and the 14-year consensus process.
- Stat News. "PCOS's new name is PMOS, a small letter change that required a big scientific process." https://www.statnews.com/2026/05/12/pcos-now-called-pmos-polyendocrine-metabolic-ovarian-syndrome/. Published: May 12, 2026. Supports: Details on the voting process, dissenting views, transition timeline, survey methodology, and patient advocate perspectives.
- Endocrine Society. "Polyendocrine Metabolic Ovarian Syndrome: New name to improve diagnosis and care of condition affecting 170 million women worldwide." https://www.endocrine.org/news-and-advocacy/news-room/2026/pcos-name-change. Published: May 12, 2026. Supports: Organizational endorsement, patient impact statements, condition characteristics, and implementation campaign details.
- Teede HJ, et al. EClinicalMedicine (reported via Healio). "Name change for 'outdated' PCOS term backed by majority of health professionals, patients." https://www.healio.com/news/womens-health-ob-gyn/20250606/name-change-for-outdated-pcos-term-backed-by-majority-of-health-professionals-patients. Published: June 6, 2025. Supports: Survey data showing 85.6% of patients and 76.1% of health professionals supported a name change, and preferred terminology.
- Mayo Clinic. "Polycystic ovary syndrome (PCOS) - Symptoms and causes." https://www.mayoclinic.org/diseases-conditions/pcos/symptoms-causes/syc-20353439. Updated: April 21, 2026. Supports: Overview of symptoms, insulin resistance mechanism, and complications including metabolic and mental health risks.
- American Academy of Family Physicians (AAFP). "Diagnosis and Treatment of Polycystic Ovary Syndrome." https://www.aafp.org/pubs/afp/issues/2016/0715/p106.html. Published: July 15, 2016. Supports: Rotterdam diagnostic criteria and the nonspecific nature of polycystic-appearing ovaries.
- CMAJ. "Diagnosis and management of polycystic ovarian syndrome." https://www.cmaj.ca/content/196/3/E85. Published: January 28, 2024. Supports: Fertility considerations, pregnancy risks, and first-line management approaches.
Comments are welcome. Please keep your comments respectful and avoid sharing personal medical information. Content on Healthy89 is for educational purposes only and should not replace professional medical advice.